Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201201121 Principal Investigator: Govindan, Ramaswamy
Title: A Randomized, Phase II, Multicenter, Double-Blind, Placebo Controlled Study Evaluating the Efficacy and Safety of MetMAb in Combination with Paclitaxel + Cisplatin or Carboplatin as First-Line Treatment for Patients with Stage IIIb (T4 Disease) or IV Squamous Non–Small Cell Lung Cancer (NSCLC)
Phase: II Disease Site: Lung
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu
Description:
The purpose of this research study is help to determine whether a research agent called MetMAB is safe and effective when given to patients with advanced NSCLC in combination with paclitaxel, and either cisplatin or carboplatin, drugs that are commonly used to treat this type of cancer.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)